Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

bioAffinity Technologies (BIAF) Non-Current Assets: 2022-2025

Historic Non-Current Assets for bioAffinity Technologies (BIAF) over the last 3 years, with Sep 2025 value amounting to $2.9 million.

  • bioAffinity Technologies' Non-Current Assets fell 26.73% to $2.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $2.9 million, marking a year-over-year decrease of 26.73%. This contributed to the annual value of $3.8 million for FY2024, which is 10.13% down from last year.
  • According to the latest figures from Q3 2025, bioAffinity Technologies' Non-Current Assets is $2.9 million, which was down 4.85% from $3.1 million recorded in Q2 2025.
  • bioAffinity Technologies' 5-year Non-Current Assets high stood at $4.2 million for Q4 2023, and its period low was $7,781 during Q3 2022.
  • For the 3-year period, bioAffinity Technologies' Non-Current Assets averaged around $3.1 million, with its median value being $3.8 million (2024).
  • As far as peak fluctuations go, bioAffinity Technologies' Non-Current Assets skyrocketed by 53,611.03% in 2023, and later fell by 26.73% in 2025.
  • Quarterly analysis of 4 years shows bioAffinity Technologies' Non-Current Assets stood at $220,438 in 2022, then skyrocketed by 1,827.44% to $4.2 million in 2023, then declined by 10.13% to $3.8 million in 2024, then decreased by 26.73% to $2.9 million in 2025.
  • Its Non-Current Assets was $2.9 million in Q3 2025, compared to $3.1 million in Q2 2025 and $3.7 million in Q1 2025.